Actress Chrissy Metz recently shared her decision to begin using GLP-1 medication. The 45-year-old star of This Is Us spent years as a skeptic regarding these drugs, noting she researched the topic extensively before committing to the treatment. Her medical choice follows a history of family health issues and her own experiences with perimenopause.
Metz highlights that previous attempts to manage her health through dieting and therapy did not provide the long-term results she wanted. Since starting the medication, she reports a significant reduction in food noise, which she describes as the constant, intrusive thoughts about eating that previously occupied her mind. She noted that she no longer feels the need to obsess over her meals throughout the day.
Beyond weight management, Metz notes that the physical benefits have impacted her daily life and work. She reports decreased joint pain and inflammation, which helps her perform on stage in her current Broadway role in & Juliet. These improvements in mobility have been a clear priority for her health goals.
Addressing public criticism, Metz maintains that she is prioritizing her own medical needs over outside opinions. She acknowledges that public scrutiny often follows her regardless of her choices, but she remains firm in her commitment to her personal health strategy. The actress is currently partnering with the telehealth provider Ro to support her treatment.
This decision marks a shift in her approach to wellness after decades of focusing on traditional methods. By focusing on her specific family medical history and her immediate health concerns, Metz says she is doing what is best for her own future.

